 | Zacks Investment Research Upgrades Revolution Medicines (NASDAQ:RVMD) to "Hold"
marketbeat.com - March 25 at 2:55 AM |
 | Insider Selling: Revolution Medicines, Inc. (NASDAQ:RVMD) Director Sells 18,215 Shares of Stock
americanbankingnews.com - April 7 at 7:32 PM |
| Revolution Medicines, Inc. (NASDAQ:RVMD) Director Sells $1,274,656.80 in Stock
americanbankingnews.com - April 7 at 7:32 PM |
 | iShares MSCI India ETF (INDA.MX)
in.finance.yahoo.com - April 6 at 8:40 AM |
| This 2020 Biotech IPO Is Poised to Break Out in 2021
finance.yahoo.com - April 2 at 7:49 AM |
| Revolution Medicines Announces Six Presentations at the American Association for Cancer Research Annual Meeting 2021
finance.yahoo.com - March 11 at 7:59 PM |
| Revolution Medicines to Participate in Digital RAS-Targeted Drug Discovery Summit and Upcoming Investor Conferences
finance.yahoo.com - February 18 at 9:45 AM |
| Estimating The Fair Value Of Revolution Medicines, Inc. (NASDAQ:RVMD)
finance.yahoo.com - February 9 at 3:06 PM |
| Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
finance.yahoo.com - February 8 at 6:20 PM |
| Revolution Medicines Raises $260.9 Million In Upsized Offering
finance.yahoo.com - February 4 at 1:52 PM |
|
| Revolution Medicines Announces Pricing of Upsized $260.9 Million Public Offering of Common Stock
finance.yahoo.com - February 4 at 12:14 AM |
| Revolution Medicines to Provide R&D Pipeline Update, Including Progress of RAS(ON) Inhibitor Programs, During Presentation at 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 5 at 9:25 AM |
| Is RVMD A Good Stock To Buy Now?
finance.yahoo.com - December 15 at 11:50 PM |
| We Think Revolution Medicines (NASDAQ:RVMD) Can Afford To Drive Business Growth
finance.yahoo.com - November 26 at 12:37 PM |
 | Why Revolution Medicines Stock Is Trading Higher
benzinga.com - November 12 at 7:57 PM |
 | Revolution Medicines EPS misses by $0.03, misses on revenue
seekingalpha.com - November 12 at 9:52 AM |
| Revolution Medicines Reports Third Quarter 2020 Financial Results and Update on Corporate Progress
finance.yahoo.com - November 12 at 9:52 AM |
| Revolution Medicines' RMC-4630 shows anti-tumor activity in colorectal cancer; collaborates with AstraZeneca
seekingalpha.com - October 26 at 3:17 AM |
| Revolution Medicines Reports Progress and Expansion of Combination Strategy with RMC-4630 as Therapeutic Backbone for RAS-Addicted Cancers
finance.yahoo.com - October 24 at 12:45 PM |
 | Revolution Medicines to Present Interim Data at ENA 2020 from Phase 1b/2 Clinical Trial Combining RMC-4630 with Cobimetinib for
bloomberg.com - October 14 at 1:55 PM |
| Revolution Medicines to Present Interim Data at ENA 2020 from Phase 1b/2 Clinical Trial Combining RMC-4630 with Cobimetinib for RAS-Addicted Solid Tumors
finance.yahoo.com - October 14 at 2:58 AM |
| Revolution Medicines to present interim data from early-stage cancer study in an upcoming symposium
seekingalpha.com - October 12 at 4:39 PM |
 | Revolution Medicines (RVMD) Looks Good: Stock Adds 6.9% in Session
nasdaq.com - September 22 at 2:05 PM |
| High Hopes for Amgen and Gilead at Europe’s Biggest Cancer Research Conference
finance.yahoo.com - September 18 at 6:05 PM |
| Revolution Medicines Reports Preclinical Tumor Regressions Induced by First-in-Class KRAS-G12D(ON) Inhibitors
finance.yahoo.com - September 16 at 1:36 PM |
| Revolution Medicines to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
finance.yahoo.com - September 9 at 10:24 AM |
| Revolution Medicines to Participate in 2nd Annual RAS-Targeted Drug Development Conference
finance.yahoo.com - September 8 at 8:15 AM |
| Here's What Revolution Medicines, Inc.'s (NASDAQ:RVMD) Shareholder Ownership Structure Looks Like
finance.yahoo.com - August 28 at 12:42 PM |
|
| Here's What Revolution Medicines, Inc.'s (NASDAQ:RVMD) Shareholder Ownership Structure Looks Like
finance.yahoo.com - August 28 at 12:42 PM |
| Revolution Medicines, Inc. (RVMD)
ca.finance.yahoo.com - August 16 at 7:22 AM |
 | Revolution Medicines Inc.
barrons.com - August 16 at 7:22 AM |
 | Revolution Medicines Inc
reuters.com - August 12 at 9:39 AM |
| Revolution Medicines EPS misses by $0.10, misses on revenue
seekingalpha.com - August 10 at 5:48 PM |
| Revolution Medicines Reports Second Quarter 2020 Financial Results and Provides Update on Corporate Progress
finance.yahoo.com - August 10 at 7:47 AM |
| Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
finance.yahoo.com - July 13 at 9:26 PM |
| Revolution Medicines (RVMD) Catches Eye: Stock Jumps 10.2%
finance.yahoo.com - July 13 at 10:00 AM |
| Revolution Medicines Announces Proposed Public Offering of Common Stock
finance.yahoo.com - July 6 at 8:02 PM |
| Revolution Medicines Reports New Application of Tri-Complex Modality for “Undruggable” Protein Targets and Announces License to Ginkgo Bioworks to Explore Potential Use Against Novel Coronavirus
finance.yahoo.com - June 30 at 5:47 PM |
| Hedge Funds Are Cashing Out Of Innovative Industrial Properties, Inc. (IIPR)
finance.yahoo.com - June 28 at 6:07 PM |
| Hedge Funds Are Piling Into Avanos Medical (AVNS)
finance.yahoo.com - June 28 at 6:07 PM |
| Revolution Medicines Provides Research and Development Update for its Portfolio of Novel Targeted Cancer Therapies
finance.yahoo.com - June 22 at 7:27 PM |
| Revolution Medicines Announces Dosing of First Patient in Clinical Study of RMC-4630 (SAR442720) Combined with PD-1 Inhibitor
finance.yahoo.com - June 22 at 9:25 AM |
| Revolution Medicines Announces Dosing of First Patient in Phase 1b Combination Study of RMC-4630 and AMG 510
finance.yahoo.com - June 9 at 10:07 AM |
| Revolution Medicines Reports First Quarter 2020 Financial Results and Continued Corporate Progress
finance.yahoo.com - May 14 at 5:52 PM |
 | Bill.com Holdings, Inc. (BILL) Q3 2020 Earnings Call Transcript
www.fool.com - May 8 at 2:23 PM |
| Revolution Medicines Announces Publication of Scientific Paper Describing Anti-Tumor Immunity Induced by SHP2 Inhibitor in Preclinical Cancer Models
finance.yahoo.com - April 29 at 10:53 AM |
| New Clinical Trial Exploring Revolution Medicines’ Investigational SHP2 Inhibitor RMC-4630 in Combination with an ERK Inhibitor Announced by Netherlands Cancer Institute
finance.yahoo.com - March 9 at 8:20 AM |
 | Revolution Medicines Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
www.marketwatch.com - February 20 at 8:42 PM |
| Revolution Medicines shares soar 85% in trading debut after IPO priced at top end of range
finance.yahoo.com - February 20 at 10:40 AM |
| The Funded: 7 Bay Area startups raise over $135M at week's end
finance.yahoo.com - February 20 at 10:40 AM |
| Revolution Medicines Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - February 20 at 10:40 AM |
